Literature DB >> 16142711

An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility.

Annette H M van der Helm-van Mil1, Tom W J Huizinga, Geziena M Th Schreuder, Ferdinand C Breedveld, René R P de Vries, René E M Toes.   

Abstract

OBJECTIVE: To prospectively investigate the effect of the DERAA-encoding HLA alleles on disease susceptibility and severity in a large cohort of patients with rheumatoid arthritis (RA), and to differentiate protective effects from non-predisposition by comparing subgroups of patients with an equal amount of predisposition alleles.
METHODS: HLA class II alleles were determined in 440 patients with early RA and in 423 healthy controls. In order to study the effect of HLA on disease severity, radiographic joint destruction was evaluated, using the modified Sharp/van der Heijde method, during 4 years of followup.
RESULTS: The presence of DERAA-encoding HLA-DRB1 alleles conferred a lower risk of developing RA for both the presence and absence of SE alleles (odds ratio 0.6). At all time points, radiographic destruction was significantly less severe in DERAA-positive patients with 1 SE allele compared with DERAA-negative patients with 1 SE allele. Additionally, a protective effect of DERAA was detected in the groups of patients who were prone to having more severe disease because of the presence of anti-cyclic citrullinated peptide antibodies or because of smoking.
CONCLUSION: DERAA-encoding HLA-DRB1 alleles independently protect against RA and are associated with less severe disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142711     DOI: 10.1002/art.21272

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  26 in total

Review 1.  Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis.

Authors:  Vincent van Drongelen; Joseph Holoshitz
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

2.  Reshaping Cinderella's slipper: the shared epitope hypothesis.

Authors:  Robert Winchester
Journal:  Arthritis Res Ther       Date:  2006-05-22       Impact factor: 5.156

3.  Association of valine and leucine at HLA-DRB1 position 11 with radiographic progression in rheumatoid arthritis, independent of the shared epitope alleles but not independent of anti-citrullinated protein antibodies.

Authors:  H W van Steenbergen; S Raychaudhuri; L Rodríguez-Rodríguez; S Rantapää-Dahlqvist; E Berglin; R E M Toes; T W J Huizinga; B Fernández-Gutiérrez; P K Gregersen; A H M van der Helm-van Mil
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

4.  Developing potent backbone cyclic peptides bearing the shared epitope sequence as rheumatoid arthritis drug-leads.

Authors:  Shirly Naveh; Yftah Tal-Gan; Song Ling; Amnon Hoffman; Joseph Holoshitz; Chaim Gilon
Journal:  Bioorg Med Chem Lett       Date:  2011-11-04       Impact factor: 2.823

5.  HLA-DRB1 and HLA-DQB1 allele associations in an Albanian patient population with rheumatoid arthritis: correlations with the specific autoantibody markers and inter-population DRB1 allele frequency variability.

Authors:  Margarita Prifti-Kurti; José Manuel Nunes; Erkena Shyti; Zamira Ylli; Alicia Sanchez-Mazas; Genc Sulcebe
Journal:  Rheumatol Int       Date:  2014-01-01       Impact factor: 2.631

6.  Acquisition of the rheumatoid arthritis HLA shared epitope through microchimerism.

Authors:  Zhen Yan; Tessa Aydelotte; V K Gadi; Katherine A Guthrie; J Lee Nelson
Journal:  Arthritis Rheum       Date:  2011-03

7.  Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor.

Authors:  Alejandro Balsa; Arancha Cabezón; Gisela Orozco; Tatiana Cobo; Eugenia Miranda-Carus; Miguel Angel López-Nevot; José Luis Vicario; Emilio Martín-Mola; Javier Martín; Dora Pascual-Salcedo
Journal:  Arthritis Res Ther       Date:  2010-04-06       Impact factor: 5.156

8.  Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.

Authors:  So-Young Bang; Tae-Un Han; Chan-Bum Choi; Yoon-Kyoung Sung; Sang-Cheol Bae; Changwon Kang
Journal:  Arthritis Res Ther       Date:  2010-06-10       Impact factor: 5.156

9.  Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development.

Authors:  Anouk L Feitsma; Jane Worthington; Annette H M van der Helm-van Mil; Darren Plant; Wendy Thomson; Jennie Ursum; Dirkjan van Schaardenburg; Irene E van der Horst-Bruinsma; Jon J van Rood; Tom W J Huizinga; René E M Toes; René R P de Vries
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

Review 10.  Current concepts in the pathogenesis of early rheumatoid arthritis.

Authors:  Arthur G Pratt; John D Isaacs; Derek L Mattey
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-02       Impact factor: 4.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.